Robert T. Lum
20Patents
9h-index
39Co-inventors
75Inventor score
Filing activity: May 31, 1995 → Mar 7, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5866702A | Purine inhibitors of cyclin dependent kinase 2 | Chemistry; Metallurgy | 102 | Expired |
| US5789416A | N.sup.6 mono heterocyclic substituted adenosine derivatives | Human Necessities | 57 | Expired |
| US6075150A | .alpha.-ketoamide inhibitors of 20S proteasome | Human Necessities | 55 | Expired |
| US6781000B1 | Alpha-ketoamide inhibitors of 20S proteasome | Human Necessities | 40 | Expired |
| US6337338B1 | Heteroaryl-aryl ureas as IGF-1 receptor antagonists | Human Necessities | 32 | Expired |
| US6794390B2 | Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha | Chemistry; Metallurgy | 31 | Expired |
| US5834487A | Inhibition of 26S and 20S proteasome by indanones | Chemistry; Metallurgy | 17 | Expired |
| US6506739B1 | Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents | Chemistry; Metallurgy | 13 | Expired |
| US7029695B2 | Therapeutic compositions containing glutathione analogs | Human Necessities | 11 | Expired |
| US5656660A | Compositions and methods for treating mast-cell mediated conditions | Chemistry; Metallurgy | 8 | Expired |
| US6790958B2 | Purine inhibitors of cyclin dependent kinase 2 & IKBA | Physics | 7 | Expired |
| US7109330B2 | Purine inhibitors of cyclin dependent kinase 2 and IκB-α | Physics | 4 | Expired |
| US6117887A | Inhibition of 26S and 20S proteasome by indanones | Chemistry; Metallurgy | 3 | Expired |
| US6479548B2 | Substituted stilbenes as glucose uptake enhancers | Chemistry; Metallurgy | 3 | Expired |
| US6458998B1 | Naphthalene ureas as glucose uptake enhancers | Chemistry; Metallurgy | 1 | Expired |
| US7071231B2 | Naphthalene ureas as glucose uptake enhancers | Chemistry; Metallurgy | 1 | Expired |
| US11834412B2 | Derivatives of aryl hydrocarbon receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US6653321B1 | Naphthylsulfonic acids and related compounds as glucose uptake agonists | Chemistry; Metallurgy | 0 | Expired |
| US6528037B2 | Method for determining whether a compound is an insulin receptor kinase activator | Physics | 0 | Expired |
| US8361971B2 | Tablet formulation of ezatiostat | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.